Marathon Petroleum Exceeds Q2 Estimates

Marathon Petroleum Corp (NYSE: MPC) reported a Q2 FY23 revenue declined to $36.8 billion from $54.2 billion, 

Marathon Petroleum Corp (NYSE:MPC) reported a Q2 FY23 revenue declined to $36.8 billion from $54.2 billion, beating the consensus of $31.02 billion.

EPS for the quarter was $5.32, above the consensus of $4.55.

Adjusted EBITDA was $4.5 billion for the quarter, compared with $9.1 billion in Q2 2022.

Income from operations totaled $3.3 billion, compared to $8.3 billion a year ago.

Q2 Refining operating costs per barrel were $5.15 versus $5.19 a year ago.

Refining & Marketing refined product sales volume for the quarter was 3,581 mbpd (vs. 3,615 a year ago); Crude oil capacity utilization was 93% vs. 100% in Q2 2022.  

As of June 30, 2023, MPC held $11.5 billion of cash, cash equivalents, short-term investments, and $5 billion available on its bank revolving credit facility.

During the quarter, the company returned $3.4 billion of capital through $3.1 billion of share repurchases and $316 million of dividends.

In July, it repurchased $0.8 billion in shares and has around $6.3 billion available under its share repurchase authorizations. 

Price Action: MPC shares are trading higher by 1.2% at $134.63 on the last check Tuesday.

Total
0
Shares
Related Posts
Read More

Eli Lilly And Company Announced Results Of The CHALLENGE-MIG Clinical Trial Of Emgality In Episodic Migraine Prevention; Did Not Achieve Statistical Superiority Versus Active Comparator On The Primary Endpoint

Emgality demonstrated robust efficacy for patients consistent with previous studies, although it did not achieve statistical superiority versus active comparator on the primary endpointEmgality performed numerically

LLY